BRIEF-60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract

Reuters03-18 20:06
BRIEF-<a href="https://laohu8.com/S/SXTPW">60 Degrees</a> Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract

March 18 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:

  • 60 DEGREES PHARMACEUTICALS FILES NEW DIETARY INGREDIENT NOTIFICATION (NDIN) WITH FDA FOR AUSTRALIAN CHESTNUT EXTRACT

  • 60 DEGREES PHARMACEUTICALS INC - FDA HAS UNTIL MAY 25, 2026 TO OBJECT TO NDIN FOR AUSTRALIAN CHESTNUT EXTRACT

Source text: ID:nGNX8XF4qH

Further company coverage: SXTP.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment